article thumbnail

Clustering Fragment Screening Hits With a Self-Organizing Map

Practical Cheminformatics

Anyway, I used a method similar to the one described in this blog post , which exploits the AllChem.AssignBondOrdersFromTemplate method in the RDKit. Cluster the fragment structures Readers of this blog probably know about my fondness for Self-Organizing Maps (SOMs), which I wrote about here and here.

article thumbnail

COVID-19 stuff

Molecular Design

|| next >> It’s been ages since the last blog post. However, I do realize that many people only follow the blog for the April Fools posts so I’ll link them here for easy reference [ 2013 | 2015 | 2016 | 2017 | 2018 | 2019 ]. Martin and I wrote a short article which we uploaded to figshare and Martin also did a blog post.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tom Lehrer's guide to design of SARS-CoV-3 main protease inhibitors for treatment of COVID-32

Molecular Design

> It’s been ages since my last COVID-19 post (How not to repurpose a 'drug') and I’ll kick blogging off for 2021 with a follow up to an even older post (SARS-CoV-2 main protease. Crowdsourcing, peptidomimetics and fragments).

article thumbnail

SARS-CoV-2 main protease. Crowdsourcing, peptidomimetics and fragments

Molecular Design

A number of peptidomimetic Mpro inhibitors have been described in the literature and this blog post by Chris Southan may be of interest. It’s also worth mentioning that fragment screens have been run against SARS-CoV-2 Nsp3 macrodomain at UCSF and Diamond since there are no known inhibitors for this target.

article thumbnail

Reinventing the small molecule toolbox: from proteins to RNA

Dark Matter Blog

We sampled several screening platforms in the course of our efforts, including fragment screening using ligand-observed nuclear magnetic resonance (NMR), DNA-encoded libraries (DEL), and SEC-MS. Each of these platforms is thoroughly vetted in protein world, but using them on RNA can yield surprising results.

article thumbnail

SARS-CoV-2 Protease Inhibitors: An Attractive Approach for Treating COVID-19

PerkinElmer

The second virtual screen focused on optimization of a hit from a previous crystallographic fragment screen. Fragment-to-lead optimization was guided by searches in a library of millions of compounds combined with docking screens to select the best candidate. Journal of the American Chemical Society.

article thumbnail

Why fragments?

Molecular Design

Paramin panorama Crystallographic fragment screens have been run recently against the main protease (at Diamond ) and the Nsp3 macrodomain (at UCSF and Diamond ) of SARS-Cov-2 and I thought that it might be of interest to take a closer look at why we screen fragments.